2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Phil J Stephens, PhD

Chief Scientific Officer
Foundation Medicine, Inc.
150 Second Street
Cambridge, MA
USA 02141

Papers:
152 Comprehensive genomic profiling of advanced stage endometrioid endometrial adenocarcinomas (EEAC) reveals differences associated with CTNNB1 mutation status and a high frequency of clinically relevant genomic alterations